73 related articles for article (PubMed ID: 17242519)
1. High-resolution diffracting crystals of intrinsically active p38alpha MAP kinase: a case study for low-throughput approaches.
Diskin R; Engelberg D; Livnah O
Acta Crystallogr D Biol Crystallogr; 2007 Feb; 63(Pt 2):260-5. PubMed ID: 17242519
[TBL] [Abstract][Full Text] [Related]
2. Improved expression, purification, and crystallization of p38alpha MAP kinase.
Bukhtiyarova M; Northrop K; Chai X; Casper D; Karpusas M; Springman E
Protein Expr Purif; 2004 Sep; 37(1):154-61. PubMed ID: 15294293
[TBL] [Abstract][Full Text] [Related]
3. Structures of p38alpha active mutants reveal conformational changes in L16 loop that induce autophosphorylation and activation.
Diskin R; Lebendiker M; Engelberg D; Livnah O
J Mol Biol; 2007 Jan; 365(1):66-76. PubMed ID: 17059827
[TBL] [Abstract][Full Text] [Related]
4. Mutagenesis of p38alpha MAP kinase establishes key roles of Phe169 in function and structural dynamics and reveals a novel DFG-OUT state.
Bukhtiyarova M; Karpusas M; Northrop K; Namboodiri HV; Springman EB
Biochemistry; 2007 May; 46(19):5687-96. PubMed ID: 17441692
[TBL] [Abstract][Full Text] [Related]
5. Active mutants of the TCR-mediated p38α alternative activation site show changes in the phosphorylation lip and DEF site formation.
Tzarum N; Diskin R; Engelberg D; Livnah O
J Mol Biol; 2011 Feb; 405(5):1154-69. PubMed ID: 21146537
[TBL] [Abstract][Full Text] [Related]
6. The three-dimensional structure of MAP kinase p38beta: different features of the ATP-binding site in p38beta compared with p38alpha.
Patel SB; Cameron PM; O'Keefe SJ; Frantz-Wattley B; Thompson J; O'Neill EA; Tennis T; Liu L; Becker JW; Scapin G
Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):777-85. PubMed ID: 19622861
[TBL] [Abstract][Full Text] [Related]
7. High-throughput screening to identify inhibitors which stabilize inactive kinase conformations in p38alpha.
Simard JR; Grütter C; Pawar V; Aust B; Wolf A; Rabiller M; Wulfert S; Robubi A; Klüter S; Ottmann C; Rauh D
J Am Chem Soc; 2009 Dec; 131(51):18478-88. PubMed ID: 19950957
[TBL] [Abstract][Full Text] [Related]
8. The discovery of novel protein kinase inhibitors by using fragment-based high-throughput x-ray crystallography.
Gill A; Cleasby A; Jhoti H
Chembiochem; 2005 Mar; 6(3):506-12. PubMed ID: 15696598
[TBL] [Abstract][Full Text] [Related]
9. Crystallization of MAP kinases.
Lee SJ; Zhou T; Goldsmith EJ
Methods; 2006 Nov; 40(3):224-33. PubMed ID: 16829129
[TBL] [Abstract][Full Text] [Related]
10. A screening system for the identification of refolding conditions for a model protein kinase, p38alpha.
Cowan RH; Davies RA; Pinheiro TT
Anal Biochem; 2008 May; 376(1):25-38. PubMed ID: 18294951
[TBL] [Abstract][Full Text] [Related]
11. Life in the fast lane for protein crystallization and X-ray crystallography.
Pusey ML; Liu ZJ; Tempel W; Praissman J; Lin D; Wang BC; Gavira JA; Ng JD
Prog Biophys Mol Biol; 2005 Jul; 88(3):359-86. PubMed ID: 15652250
[TBL] [Abstract][Full Text] [Related]
12. A novel lipid binding site formed by the MAP kinase insert in p38 alpha.
Diskin R; Engelberg D; Livnah O
J Mol Biol; 2008 Jan; 375(1):70-9. PubMed ID: 17999933
[TBL] [Abstract][Full Text] [Related]
13. Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804.
Xing L; Shieh HS; Selness SR; Devraj RV; Walker JK; Devadas B; Hope HR; Compton RP; Schindler JF; Hirsch JL; Benson AG; Kurumbail RG; Stegeman RA; Williams JM; Broadus RM; Walden Z; Monahan JB
Biochemistry; 2009 Jul; 48(27):6402-11. PubMed ID: 19496616
[TBL] [Abstract][Full Text] [Related]
14. DEF pocket in p38α facilitates substrate selectivity and mediates autophosphorylation.
Tzarum N; Komornik N; Ben Chetrit D; Engelberg D; Livnah O
J Biol Chem; 2013 Jul; 288(27):19537-47. PubMed ID: 23671282
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38alpha in abrogating myoblast proliferation.
Perdiguero E; Ruiz-Bonilla V; Gresh L; Hui L; Ballestar E; Sousa-Victor P; Baeza-Raja B; Jardí M; Bosch-Comas A; Esteller M; Caelles C; Serrano AL; Wagner EF; Muñoz-Cánoves P
EMBO J; 2007 Mar; 26(5):1245-56. PubMed ID: 17304211
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the high-affinity binding of pyrrolotriazine inhibitors of p38 MAP kinase.
Sack JS; Kish KF; Pokross M; Xie D; Duke GJ; Tredup JA; Kiefer SE; Newitt JA
Acta Crystallogr D Biol Crystallogr; 2008 Jul; D64(Pt 7):705-10. PubMed ID: 18566506
[TBL] [Abstract][Full Text] [Related]
17. Uniaxial stretch-induced regulation of mitogen-activated protein kinase, Akt and p70 S6 kinase in the ageing Fischer 344 x Brown Norway rat aorta.
Rice KM; Desai DH; Preston DL; Wehner PS; Blough ER
Exp Physiol; 2007 Sep; 92(5):963-70. PubMed ID: 17526558
[TBL] [Abstract][Full Text] [Related]
18. p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis.
Dolado I; Swat A; Ajenjo N; De Vita G; Cuadrado A; Nebreda AR
Cancer Cell; 2007 Feb; 11(2):191-205. PubMed ID: 17292829
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
20. p38alpha and p38delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells.
Junttila MR; Ala-Aho R; Jokilehto T; Peltonen J; Kallajoki M; Grenman R; Jaakkola P; Westermarck J; Kähäri VM
Oncogene; 2007 Aug; 26(36):5267-79. PubMed ID: 17334397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
